54 related articles for article (PubMed ID: 32879437)
21. Comparison of the Latin America Regulation Landscape and International Reference Health Authorities to Hasten Drug Registration and Clinical Research Applications.
Argotti U; Leyens L; Lisbona C; López P; Alonso-Orgaz S; Nevado A; Cozzi V
Ther Innov Regul Sci; 2023 Nov; 57(6):1287-1297. PubMed ID: 37682461
[TBL] [Abstract][Full Text] [Related]
22. Use of the Certificate for Pharmaceutical Products (CPP) in 18 Maturing Pharmaceutical Markets: Comparing Agency Guidelines with Company Practice.
Rodier C; Bujar M; McAuslane N; Patel P; Liberti L
Ther Innov Regul Sci; 2021 Jan; 55(1):118-128. PubMed ID: 32617911
[TBL] [Abstract][Full Text] [Related]
23. WHO collaborative registration procedure using stringent regulatory authorities' medicine evaluation: reliance in action?
Vaz A; Roldão Santos M; Gwaza L; Mezquita González E; Pajewska Lewandowska M; Azatyan S; Saint-Raymond A
Expert Rev Clin Pharmacol; 2022 Jan; 15(1):11-17. PubMed ID: 35130803
[TBL] [Abstract][Full Text] [Related]
24. Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.
Ahonkhai V; Martins SF; Portet A; Lumpkin M; Hartman D
PLoS One; 2016; 11(11):e0166515. PubMed ID: 27851831
[TBL] [Abstract][Full Text] [Related]
25. Registration pathways to accelerate regulatory assessment of innovative medicines in Latin America.
Padua A; Partika L; Bonamici D; Rahal Cabello J; Kohiyama C; Spinardi P; Castro A; Rolim A; Souto F
J Public Health Policy; 2020 Dec; 41(4):481-495. PubMed ID: 32879437
[TBL] [Abstract][Full Text] [Related]
26. Strengthening vaccination policies in Latin America: an evidence-based approach.
Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
[TBL] [Abstract][Full Text] [Related]
27. Biosimilars in psoriasis: Clinical practice and regulatory perspectives in Latin America.
de la Cruz C; de Carvalho AV; Dorantes GL; Londoño Garcia AM; Gonzalez C; Maskin M; Podoswa N; Redfern JS; Valenzuela F; van der Walt J; Romiti R
J Dermatol; 2017 Jan; 44(1):3-12. PubMed ID: 27461455
[TBL] [Abstract][Full Text] [Related]
28. Follow-on products for treatment of multiple sclerosis in Latin America: An update.
Correale J
J Neurol Sci; 2017 Oct; 381():153-159. PubMed ID: 28991670
[TBL] [Abstract][Full Text] [Related]
29. Regulatory Pathways Supporting Expedited Drug Development and Approval in ICH Member Countries.
Franco P; Jain R; Rosenkrands-Lange E; Hey C; Koban MU
Ther Innov Regul Sci; 2023 May; 57(3):484-514. PubMed ID: 36463352
[TBL] [Abstract][Full Text] [Related]
30. Challenges facing drug utilization research in the Latin American region.
Salas M; Lopes LC; Godman B; Truter I; Hartzema AG; Wettermark B; Fadare J; Burger JR; Appenteng K; Donneyong M; Arias A; Ankrah D; Ogunleye OO; Lubbe M; Horne L; Bernet J; Gómez-Galicia DL; Del Carmen Garcia Estrada M; Oluka MN; Massele A; Alesso L; Herrera Comoglio R; da Costa Lima E; Vilaseca C; Bergman U
Pharmacoepidemiol Drug Saf; 2020 Nov; 29(11):1353-1363. PubMed ID: 32419226
[TBL] [Abstract][Full Text] [Related]
31. Cooperation Agreements, Memorandums of Understanding, and Letters of Intent as Instruments to Facilitate the Implementation of Reliance in Latin America.
Rodríguez H; De Lucia ML; Liberti L
Clin Ther; 2022 Aug; 44(8):1107-1128. PubMed ID: 35798570
[TBL] [Abstract][Full Text] [Related]
32. Building a Better Approach for the Benefit of Patients: 10 Pillars to Strengthen Regulatory Review Systems Globally.
O'Brien J; Lumsden RS; Diehl DH; Macdonald JC
Ther Innov Regul Sci; 2020 Mar; 54(2):283-292. PubMed ID: 32072580
[TBL] [Abstract][Full Text] [Related]
33. UK medicines regulation: responding to current challenges.
Richards N; Hudson I
Br J Clin Pharmacol; 2016 Dec; 82(6):1471-1476. PubMed ID: 27580254
[TBL] [Abstract][Full Text] [Related]
34. WHO Expert Committee on specifications for pharmaceutical preparations.
World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445
[TBL] [Abstract][Full Text] [Related]
35. The WHO Global Benchmarking Tool: a game changer for strengthening national regulatory capacity.
Guzman J; O'Connell E; Kikule K; Hafner T
BMJ Glob Health; 2020 Aug; 5(8):. PubMed ID: 32784212
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
